MLTX icon

MoonLake Immunotherapeutics
MLTX

Overview Fund Activity

83 hedge funds and large institutions have $2.86B invested in MoonLake Immunotherapeutics in 2023 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
+40
Holders Change %
+93.02%
% of All Funds
1.31%
Holding in Top 10
10
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+400%
% of All Funds
0.16%
New
47
Increased
25
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$172M
2
ACA
2
Avoro Capital Advisors
New York
$88M
3
CAM
3
Cormorant Asset Management
Massachusetts
$415M
4
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$58.6M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$99.1M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$103M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$70M
3
Axa
3
Axa
France
$7.9M
4
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$3.54M
5
GPP
5
Great Point Partners
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
$15.2M -$257K -5,044 -2%
MB
27
MPM BioImpact
Massachusetts
$15.1M +$15.1M +295,111 New
Invesco
28
Invesco
Georgia
$13.4M +$4.34M +85,090 +48%
SCM
29
Silverarc Capital Management
Massachusetts
$10.2M +$4.81M +94,250 +89%
Franklin Resources
30
Franklin Resources
California
$10.2M +$10.2M +200,000 New
Lord, Abbett & Co
31
Lord, Abbett & Co
New Jersey
$9.93M +$9.93M +194,703 New
Millennium Management
32
Millennium Management
New York
$9.81M +$8.02M +157,333 +449%
SAM
33
Sectoral Asset Management
Quebec, Canada
$9.41M +$9.41M +184,590 New
Morgan Stanley
34
Morgan Stanley
New York
$8.13M +$6.47M +126,906 +390%
Axa
35
Axa
France
$7.9M -$7.47M -146,422 -49%
Nuveen Asset Management
36
Nuveen Asset Management
Illinois
$7.14M +$7.14M +140,000 New
HS
37
HighVista Strategies
Massachusetts
$6.62M +$384K +7,521 +6%
SSA
38
Schonfeld Strategic Advisors
New York
$6.02M +$4.12M +80,760 +217%
O
39
OrbiMed
New York
$5.97M +$5.97M +117,000 New
DTC
40
Deep Track Capital
Connecticut
$5.53M +$5.53M +108,450 New
TD Asset Management
41
TD Asset Management
Ontario, Canada
$5.08M +$1.65M +32,328 +48%
JFG
42
Jefferies Financial Group
New York
$4.78M +$1.23M +24,076 +35%
ABG
43
Ally Bridge Group
New York
$4.66M +$947K +18,563 +25%
Goldman Sachs
44
Goldman Sachs
New York
$4.56M +$4.56M +89,501 New
ACM
45
Altium Capital Management
New York
$4.49M +$4.49M +88,000 New
PHP
46
Parkman Healthcare Partners
Connecticut
$4.08M +$4.08M +80,000 New
GIM
47
Granahan Investment Management
Massachusetts
$3.67M -$86.9K -1,703 -2%
Balyasny Asset Management
48
Balyasny Asset Management
Illinois
$3.54M -$6.55M -128,366 -65%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3.2M +$724K +14,187 +29%
Hudson Bay Capital Management
50
Hudson Bay Capital Management
Connecticut
$3.06M +$3.06M +60,000 New
1
2
3 4